Currently, available drug treatments for mild to moderate AD which target AChE exert several side-effects, such as nausea, diarrhoea, dizziness, weight loss, abdominal pain, anorexia, and vomiting [14]. This evidence concerns the gene ACHE and Alzheimer disease.